Shilpa Medicare Makes History: First Indian Company Completes Phase 1 Trial for Recombinant Human Albumin (rHA) 20 per cent

Aug 28, 2024

Raichur (Karnataka) [India], August 28: In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase...

SEC recommends Phase 1 clinical trials of Reliance's Covid Vaccine candidate

Aug 27, 2021

New Delhi [India], August 27 : The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance's recombinant COVID-19 vaccine candidate.

IIT Guwahati completes technology transfer to roll out the first recombinant vaccine for Swine Fever Virus

Mar 26, 2024

The Indian Institute of Technology Guwahati successfully transferred a pioneering vaccine technology to BioMed Pvt. Ltd., a lmanufacturing company specialising in high-quality vaccines, on...

New XBB Covid variant is immune evasive says WHO's Soumya Swaminathan

Oct 21, 2022

Pune (Maharashtra) [India], October 21 : With India reporting a highly infectious new COVID-19 variant, World Health Organization Chief Scientist Soumya Swaminathan on Friday...

Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India

Jul 08, 2021

New Delhi [India], July 8 : French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical...

What is Omicron's XBB.1.5 Sub-variant? Should India be worried?

Jan 03, 2023

According to Dr Rajeev Jayadevan, Co-chairman of the National IMA Covid task force, XBB.1.5 is an upgraded version of XBB, a recombinant sub-lineage of...